Results 201 to 210 of about 10,366,637 (362)

Green Space Production as a State Project in Urban China

open access: yesTransactions of the Institute of British Geographers, EarlyView.
Short Abstract We examine the politics of developing Chengdu's greenway project by advancing the concept of state entrepreneurialism through strategic embeddedness and tactical mobilisation. We define strategic embeddedness as the institutional integration of market into the state apparatus to achieve the state's strategic goals and tactical ...
Handuo Deng, Fulong Wu, Fangzhu Zhang
wiley   +1 more source

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

open access: yesInternational Journal of Cancer, Volume 158, Issue 6, Page 1617-1627, 15 March 2026.
What's new? PARP inhibitors are effective in patients with inactivating alterations in the BRCA1/2 genes across tumor types. However, the efficacy of PARP inhibitors in patients with other inactivated homologous recombination repair genes remains unclear. This knowledge gap and discrepancies in EMA/FDA approvals highlight the need for better biomarkers.
Ilse A. C. Spiekman   +15 more
wiley   +1 more source

Biliary PAH metabolites in European eel (Anguilla anguilla) from Mar Menor lagoon (SE Spain) [PDF]

open access: green, 2015
Ángel Gea-Pacheco   +4 more
openalex  

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

open access: yesInternational Journal of Cancer, Volume 158, Issue 6, Page 1654-1665, 15 March 2026.
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke   +30 more
wiley   +1 more source

Home - About - Disclaimer - Privacy